Farquhar John C.M. sold $1.8M of HTFL
Farquhar John C.M. (Chief Executive Officer) sold 38,900 shares of Heartflow, Inc. (HTFL) at an average of $46.78 ($46.42–$50.00, $1.82M total) across 2 trades over 2026-09-10 to 2026-09-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data on insider sentiment, useful for short-term traders.
Market read
First public disclosure of a CEO stock sale; modest relevance for traders monitoring insider activity.
What to watch
CEO may be diversifying holdings; no immediate change in company fundamentals.
Background
Form 4 filing discloses insider transactions required by SEC regulations.
Ticker impact
CEO John Farquhar sold 38,900 shares for $1.8M via a 10b5-1 plan, reducing his stake to 321,914 shares.
Possible modest downside pressure over the next few days.
Sale size is modest relative to market cap, but CEO involvement adds weight.
Market effects
Minimal impact on the broader medtech sector.
Limited to US-listed medtech investors.
Low
Counterpoint
The sale could be a routine 10b5-1 execution, not a bearish signal.
Key entities
- CompanyHeartflow, Inc.
US-listed medical device company (NASDAQ: HTFL).
- PersonJohn C.M. Farquhar
Chief Executive Officer of Heartflow.
